These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 23167665)
1. Current update in the management of diabetic nephropathy. Van Buren PN; Toto R Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665 [TBL] [Abstract][Full Text] [Related]
2. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
4. Sodium-glucose cotransporter 2 inhibition in type 1 diabetes: simultaneous glucose lowering and renal protection? Cherney DZ; Perkins BA Can J Diabetes; 2014 Oct; 38(5):356-63. PubMed ID: 25192954 [TBL] [Abstract][Full Text] [Related]
5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
6. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J; Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218 [TBL] [Abstract][Full Text] [Related]
7. Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists. Hsueh WA Curr Opin Pharmacol; 2002 Apr; 2(2):182-8. PubMed ID: 11950631 [TBL] [Abstract][Full Text] [Related]
8. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
10. New and old agents in the management of diabetic nephropathy. Lytvyn Y; Bjornstad P; Pun N; Cherney DZ Curr Opin Nephrol Hypertens; 2016 May; 25(3):232-9. PubMed ID: 26890303 [TBL] [Abstract][Full Text] [Related]
11. Management of diabetic nephropathy: Recent progress and future perspective. Ahmad J Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297 [TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy. Parving HH; Hovind P Curr Hypertens Rep; 2002 Oct; 4(5):387-93. PubMed ID: 12217258 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin blockade in type 2 diabetic renal disease. Ruilope LM; Luño J Kidney Int Suppl; 2002 Dec; (82):S61-3. PubMed ID: 12410857 [TBL] [Abstract][Full Text] [Related]
14. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy. Jacobsen P; Rossing K; Parving HH Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491 [TBL] [Abstract][Full Text] [Related]
15. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. Johnson SA; Spurney RF Am J Physiol Renal Physiol; 2015 Nov; 309(10):F807-20. PubMed ID: 26336162 [TBL] [Abstract][Full Text] [Related]
16. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
17. [The role of ramipril in the therapy of diabetic nephropathy]. Dézsi CA Orv Hetil; 2014 Feb; 155(7):263-9. PubMed ID: 24509355 [TBL] [Abstract][Full Text] [Related]
18. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies. Zanella MT; Ribeiro AB Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249 [TBL] [Abstract][Full Text] [Related]
19. Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease. Andersen NH; Mogensen CE Curr Hypertens Rep; 2004 Oct; 6(5):369-76. PubMed ID: 15341690 [TBL] [Abstract][Full Text] [Related]
20. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Zhang MZ; Wang S; Yang S; Yang H; Fan X; Takahashi T; Harris RC Am J Physiol Renal Physiol; 2012 Feb; 302(4):F433-8. PubMed ID: 22114203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]